At Macrosoft, Alexander Sterling was in the middle of an important meeting with his board members.
The agenda was monumental: with the rapid expansion of pharmaceuticals, the boards were deliberating whether Macrosoft should also dive into it.
Their competitors like Pears had followed the route recently and garnered massive profits in just a few days despite doing little to nothing.
All they were doing was—buying, transporting, and reselling the life-saving drugs at high prices. With such a thing that can give you a second life the demand was insatiable and people were practically going wild to spend any amount of money and buy it.
The conference room buzzed with lively discussions, the air thick with the aroma of coffee mingling with the faint tension as everyone showed keen interest about this new debenture they planned to enter.
Just then, a loud, creaking voice shattered the flow of the meeting.
"SIRRR!"